Clinical Trial

Effect of Phase I Cardiac Rehab With or Without Upper Limb Cycle Ergometer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to investigate the effects of an upper limb cycle ergometer in phase I CABG patients. This will likely enhance various outcomes such as quality of life, dyspnea, functional outcome measure, cardiovascular parameters, and upper limb mobility. If utilized, the arm ergometer may contribute to improve upper limb strength and endurance. This could result in improving upper limb range of motion and reducing the risk of adhesive capsulitis. This study will positively impact society by reducing morbidity and mortality rates, healthcare costs and ultimately improves patient care.
Trial Details
NCT Number NCT07128849
Lead Sponsor Riphah International University
Conditions CAD
Enrollment 44 participants
Start Date 2025-07-17
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-19